Parameter
| Biomarker | cPCs | Full name | Proportion of clonal plasma cells in bone marrow | Molecular Type | nucleic acid |
|---|---|---|---|---|---|
| Molecular Formula | Molecular Weight | Core Functional Dimensions | diagnosis, staging | ||
| Disease | Multiple Myeloma (MM) | Disease Subtypes | / | ||
| Organ | Bone marrow | Test Sample / Technology Platform | marrow | ||
| Pathobiological Mechanisms | The proportion of abnormal clonal plasma cells in the bone marrow reflects tumor burden, with higher proportions indicating poorer prognosis. | ||||
| Clinical Availability Status | International Myeloma Working Group (IMWG) | ||||
| Notes and Dynamics | ≥60% of patients require treatment even without end-organ damage; flow cytometry can simultaneously detect surface markers (CD38, CD138, CD56) to improve the accuracy of clonal identification | ||||